Anti-HCV DAA are needed whatever liver fibrosis is. The pros
Saved in:
Main Author: | Albert Tran (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-HCV DAA are needed whatever liver fibrosis is. The cons
by: Pablo Barreiro
Published: (2016) -
Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients
by: M. Coiras, et al.
Published: (2019) -
HCV: is mission accomplished? The pros
by: Stanislas Pol
Published: (2016) -
Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
by: Fabrizio Fabrizi, et al.
Published: (2021) -
Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
by: Hrvoje Roguljic, et al.
Published: (2021)